目的提取和鉴定人血清中氧化脂蛋白(a)[ox-Lp(a)]自身抗体,建立ox-Lp(a)ELISA检测法并进行临床研究。方法采用溴化氰活化的sepharose4B交联ox-Lp(a)制备免疫吸附层析柱,从正常人血清中提取抗ox-Lp(a)自身抗体,分析其免疫反应性。分别建立以抗ox-Lp(a)的自身抗体、抗氧化LDL(ox-LDL)多克隆抗体为包被抗体,酶标抗载脂蛋白(a)[apo(a)]为检测抗体的ox-Lp(a)ELISA检测法,并对100例冠心病患者和100名健康体检人群进行分析。结果8份正常人血清中均存在抗ox-Lp(a)自身抗体,与ox-Lp(a),ox-LDL均具有良好的反应性;再经亲和层析除出抗ox-LDL自身抗体后,2份标本同ox-Lp(a)仍具有较高的反应性。同对照组相比,本组冠心病患者血浆Lp(a)水平显著升高[(279.6±162.7)mg/L比(206.3±126.4)mg/L,P〈0.01];ox-Lp(a)水平亦明显增加(P〈0.01),采用自身抗体和抗ox-LDL抗体建立的ELISA法测定结果分别为:(24.3±33.4)μg/ml比(8.4±9.3)μ/ml和(13.0±13.8)μ/ml比(7.3±9.7)μ/ml;两种ELISA法间结果高度相关(r=0.78,P〈0.01)。结论提取的人血清ox-Lp(a)自身抗体可识别apo(a)和apoB氧化位点,采用自身抗体建立的ox-Lp(a)检测法能更真实、准确地反应体内Lp(a)的氧化状态,冠心病患者ox-Lp(a)水平显著升高。
Objective To isolate and identify human autoantibodies against oxidized Lp(a) [ ox-Lp (a) ] and develop new ELISA method for ox-Lp (a) by using isolated human autoantibodies as capture antibody. Methods Ox-Lp(a) autoantibodies from healthy subjects were isolated and identified by affinity chromatography. Two "sandwich" ELISA methods for plasma ox-Lp(a) were developed by using either the human autoantibodies against ox-Lp(a) or rabbit antiserum against human ox-LDL as the capture antibodies. Enzyme-labeled monoclonal anti-ape(a) was used for the quantifications. Serum ox-Lp (a) levels in 100 coronary heart disease (CHD) patients and 100 control subjects were measured with the ELISA methods. Results Ox-Lp(a) autoantibodies were isolated from all 8 studied subjects. Autoantibodies from two of the 8 sebjects showed both reactivities to ox-LDL and ox-apo(a). The Lp(a) levels in the patients with CHD were significantly different from those of control [ (279. 6 ± 162.7 ) mg/L vs (206. 3 ± 126. 4 ) mg/L, P 〈 0.0 1 ]. Plasma ox-Lp(a) levels in patients with CHD detected by two ELISAs were both significantly higher than those of control [ ELISA using human antibodies against ox-Lp(a) : (24.3 ± 33.4) μg/ml vs (8.4 ± 9. 3 ) μg/ml, P 〈 0.01 ; ELISA using antibodies against ox-LDL: ( 13.0 ± 13.8 ) μg/ml vs (7. 3 ±9.7) μg/ml, P 〈 0. 01, respectively]. Results obtained with the two ELISA methods were closely correlated (r = 0. 78, P 〈 0. 01 ). Conclusions Autoantibodies against ox-Lp (a) can recognize both ape (a) and apoB epitopes of ox-Lp (a). A new ELISA for ox-Lp (a) by using human antibodies has been developed. Increased serum ox-Lp(a) has been observed in the CHD patients.